Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Mizuho Financial Group $2 billion senior notes offering
Davis Polk advised the joint bookrunners and lead managers in connection with Mizuho Financial Group, Inc.’s SEC-registered…
Ranpak Holdings exchange offer and consent solicitation
Davis Polk advised Ranpak Holdings Corp. in connection with an offer to exchange shares of Class A common stock of the…
I-Mab $418 million private placement
Davis Polk advised the lead placement agent in connection with I-Mab’s $418 million private placement of 29,133,502 ordinary…
Globe Life $50 million senior notes reopening
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Globe Life Inc. of $50…
Tencent Music $800 million debut SEC-registered notes offering
Davis Polk advised Tencent Music Entertainment Group on its debut SEC-registered notes offering, consisting of $300 million…
Pague Menos R$746.9 million IPO
Davis Polk advised Empreendimentos Pague Menos S.A. (“Pague Menos”) in connection with its initial public offering of 87,873…
Pague Menos R$746.9 million IPO
Davis Polk advised Empreendimentos Pague Menos S.A. (“Pague Menos”) in connection with its initial public offering of 87,873…
Globe Life $50 million senior notes reopening
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Globe Life Inc. of $50…
Tencent Music $800 million debut SEC-registered notes offering
Davis Polk advised Tencent Music Entertainment Group on its debut SEC-registered notes offering, consisting of $300 million…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate…